Splenic marginal zone lymphoma (SMZL) is a rare non-Hodgkin's lymphoma that recently
has been recognized as an entity. The first goal of this study was to identify potential …

Results Auto-immune manifestations were the presenting feature of lymphoma in four cases.
Auto-immune manifestations included auto-immune cytopenia in three cases (two hemolytic …

Introduction Different entities of indolent B-cell lymphomas are thought to derive from cells of
the marginal zone (MZ). In the last lymphoma classifications (WHO 2001 and 2008), three …

Opinion statement Splenic marginal zone lymphoma with or without villous lymphocytes
(SLVL/SMZL) is a low grade B-cell lymphoma that affects patients in the sixth decade and …

The majority of splenic marginal zone lymphoma (SMZL) patients experience an indolent
clinical course; however, some cases transform to a high-grade lymphoma. Cytogenetic …

Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen,
bone marrow, and frequently the blood. SMZL lymphomagenesis involves antigen and/or …

Aims: Splenic marginal zone lymphoma (SMZL) is characterized by a micronodular infiltrate
of the splenic white pulp, centred on pre‐existing follicles, with a peripheral rim of …

The recognition and classification of the different varietiesof splenic low-grade B-cell
lymphomas have been hampered by the rarity of histological studies of surgical splenectomy …

Aims To describe 76 cases of splenic marginal zone lymphoma (SMZL), including
correlations with clinical and other characteristics. Methods and results Patients were …

Splenic marginal zone lymphoma is a rare disease, accounting for 1% of all lymphomas. We
reviewed our single center experience of 13 patients with splenic marginal zone lymphoma …